FY27 base-case growth 12-15%

RFP pipeline (active RFPs count) — The RFP pipeline has more than doubled since Q2 FY25, indicating strong demand tailwinds from innovator de-risking and new therapy areas. The number of late-stage opportunities suggests near-term conversion potential, though management has not disclosed win ra